Skip to content

Clinical trials

Phase 2 Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Clear all

1,101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200018
200118
200227
200313
200435
200543
200641
200744
200850
200931
201050
201137
201253
201331
201439
201551
201651
201741
201852
201942
202028
202153
202239
202337
202430
202537
202632

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed559
Terminated159
Active, not recruiting119
Recruiting104
Unknown status67
Withdrawn66
Not yet recruiting23
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)75
Memorial Sloan Kettering Cancer Center36
Fred Hutchinson Cancer Center35
Mayo Clinic35
M.D. Anderson Cancer Center29
University of Arkansas27
Institute of Hematology & Blood Diseases Hospital, China17
Janssen Research & Development, LLC17
Masonic Cancer Center, University of Minnesota15
Celgene14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma1,101
Neoplasms, Plasma Cell207
Lymphoma146
Lymphoma, Non-Hodgkin145
Recurrence131
Hodgkin Disease129
Leukemia, Lymphocytic, Chronic, B-Cell122
Precursor Cell Lymphoblastic Leukemia-Lymphoma110
Myelodysplastic Syndromes105
Leukemia, Myeloid, Acute100

Trials

Showing 1 to 25 of 1,101. Each trial links to its page on Pharma Observatory.

1,001 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.